ABBY DEVINE: Open Payments
NPI 1558626317 · SHEPHERDSVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$823 in 47 payments from 16 companies in 2025. Trend: 2023 $607 · 2024 $841 · 2025 $823
Food & beverage: $803Long term medical supply or device loan: $20
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 13 | $162 |
| Vanda Pharmaceuticals Inc. | 3 | $107 |
| ABBVIE INC. | 4 | $103 |
| Amgen Inc. | 5 | $83 |
| Novo Nordisk Inc | 5 | $79 |
| Medtronic, Inc. | 2 | $48 |
| GlaxoSmithKline, LLC. | 3 | $46 |
| Lilly USA, LLC | 3 | $43 |
| Abbott Laboratories | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
Products named: NURTEC ODT, HETLIOZ, OTEZLA, UBRELVY, MINIMED 780G, PREVNAR 20, MOUNJARO, Ozempic.
Industry payments across KY — which companies pay providers there.
